Story perspectives

Mayo Clinic Unveils Advanced Genetic Test for Pancreatitis

9/13/2025

Summary

Story summary

Mayo Clinic has introduced a genetic testing panel for hereditary pancreatitis, improving diagnostic accuracy and patient care.
This panel examines nine genes associated with pancreatitis, enhancing previous four-gene tests by targeting clinically relevant variants.
Whole exome sequencing (WES) provides comprehensive coverage of disease-related variants, reducing false results.
The test identifies pathogenic variants, facilitating personalized treatment and monitoring for at-risk family members.
Future research will explore polygenic risk scoring for a comprehensive risk assessment in pancreatitis.

1 of 1

Story summary

Mayo Clinic has introduced a genetic testing panel for hereditary pancreatitis, improving diagnostic accuracy and patient care.
This panel examines nine genes associated with pancreatitis, enhancing previous four-gene tests by targeting clinically relevant variants.
Whole exome sequencing (WES) provides comprehensive coverage of disease-related variants, reducing false results.
The test identifies pathogenic variants, facilitating personalized treatment and monitoring for at-risk family members.
Future research will explore polygenic risk scoring for a comprehensive risk assessment in pancreatitis.